News About: Pharm. Industry
Dongwha, Chong Kun Dang grow fast in generic drug market
With Korean pharmaceutical companies struggling to boost up their sluggish sales in the domestic ethical market, Dongwha Pharmaceutical is leading any others, with its sales growth exceeding 19 percent in the first qu...
Pharmaceutical companies’ sales likely to hit snag in next quarter
The local pharmaceutical industry is expected to suffer significant sales loss due to tightening regulations and other negative factors.
Tough regulations and intense competition at home means that firms have to lo...
GSK supplies 100 million doses of Rotarix vaccine worldwide
GlaxoSmithKline (GSK) announced recently that over 100 million doses of its rotavirus vaccine, Rotarix, have been delivered since its first launch in 2007, reflecting that around 50 million children in 120 countries h...
Zuellig Pharma Korea opens online shopping mall for drugs
Zuellig Pharma Korea has introduced an online shopping mall for domestic wholesalers and pharmacies to book prescription drugs and over-the-counter medicines simultaneously. The sales order processing is available at ...
Dong-A’s chairman Kang hesitant to sell Bacchus-D at non-drug stores
The possible reclassification of 48 over-the-counter (OTC) drugs as “quasi-drugs,” is seen as a much needed move for the industry and Dong-A Pharmaceutical, but the latter is still hesitant to use the new outlets in f...
Dong-A, GSK unable to agree on product swap
Dong-A Pharmaceutical and GlaxoSmithKline (GSK), the world’s third largest pharmaceutical firm by revenue, are said to end their negotiations to exchange their healthcare products, such as Polident, Sensodyne and Garg...
Schnell to conduct Phase I trial for biosimilar drug
Schnell Biopharmaceutical said it will carry out its Phase 1 clinical trial for its arthritis biosimilar after recent approval from the Korea Food and Drug Administration.
Schnell plans to develop and commercialize...
Drugmakers to gear up for OTC advertisements
Domestic pharmaceutical firms are moving to put more and more efforts into advertisements in a step to enhance the image of their over-the-counter (OTC) medicines
Such moves are likely to be reinforced further ahead ...
4 biologic agents on hot market competition
The domestic biological drugs market so far enjoyed by three companies - Abbott/Eisai's Humira, Johnson & Johnson’s Remicade (infliximab), Wyeth’s Enbrel (etarnercept) - may be encountered with a fierce competition wh...
Establishment of large drug distribution cooperative eyed
A total of 60 small- and medium-sized wholesalers had a convention Friday to set up a large drug logistics cooperative.
“We will share our experiences and thoughts on how to take advantage of the cooperative, emerg...
